None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subects who informed consent Healthy subjects (30-65 years)
Exclusion criteria
Exclusion criteria: BMI > 35kg/m2 body weight fluctuation of 10% or more in the past 8weeks excessive activity takes hormone therapy (female) excessive smoker drinking alcohol more than 140g/week platelet function disorder taking anti-platelet medication (aspirin, non-steroidal anti-inflammatory drugs) cardiovascular or haematological disorders, insulin resistance, diagnosed non-insulin dependent diabetes disease (Cardiovascular disease, heart failure, myocardial infarction, cerebrovascular disease, arteriosclerosis, diabetes, thyroid abnormality, ulcer, gastric bleeding, infectious diseases, systemic inflammatory diseases, acute inflammation, malignancy, renal disease, renal function, liver disease, lung disease, blood coagulopathy) take oriental medicine or other medicine during test period continuously subjects who have hypersensitivity about test material take fuctional foods continuously in the 4 weeks participate other human study in the 12 weeks pregnat woman or lactating woman subjects who unsuiable about this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation test | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood flow;Lipids | — |
Countries
Korea, Republic of
Contacts
Ewha Womans University